URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Asbury

Concepts (160)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Agents
24
1982
628
2.920
Why?
Imides
6
1993
7
1.800
Why?
Isoquinolines
6
1993
63
1.760
Why?
Thiadiazoles
7
1986
12
1.390
Why?
Uterine Neoplasms
5
1990
105
1.280
Why?
Antineoplastic Combined Chemotherapy Protocols
13
1985
436
0.860
Why?
Uterine Cervical Neoplasms
4
1987
125
0.830
Why?
Carcinoma
5
1989
194
0.830
Why?
Endometrial Neoplasms
3
1996
38
0.830
Why?
Colonic Neoplasms
6
1985
123
0.750
Why?
Carcinoma, Squamous Cell
4
1987
238
0.680
Why?
Neoplasm Recurrence, Local
5
1989
295
0.660
Why?
Lung Neoplasms
10
1983
435
0.650
Why?
Mixed Tumor, Mesodermal
2
1996
2
0.620
Why?
Leiomyosarcoma
2
1995
18
0.600
Why?
Paclitaxel
5
1995
59
0.520
Why?
Adenocarcinoma
8
1985
483
0.510
Why?
Carcinoma, Non-Small-Cell Lung
5
1994
70
0.500
Why?
Middle Aged
34
1980
10013
0.480
Why?
Etoposide
9
1983
83
0.470
Why?
Aged
28
1984
7392
0.460
Why?
Ovarian Neoplasms
4
1984
106
0.450
Why?
Goserelin
1
2002
7
0.450
Why?
Naphthalimides
6
1993
9
0.450
Why?
Antineoplastic Agents, Hormonal
1
2002
44
0.430
Why?
Female
40
1981
20222
0.410
Why?
Topotecan
1
2000
4
0.370
Why?
Adult
24
1984
11572
0.340
Why?
Humans
46
1980
37165
0.330
Why?
Esophageal Neoplasms
1
2000
133
0.320
Why?
Drug Administration Schedule
10
1984
374
0.310
Why?
Remission Induction
8
1989
165
0.300
Why?
Rectal Neoplasms
3
1985
84
0.280
Why?
Breast Neoplasms
8
1981
666
0.270
Why?
Antineoplastic Agents, Phytogenic
4
1996
37
0.270
Why?
Neoplasm Metastasis
7
1981
229
0.270
Why?
Drug Evaluation
9
1984
99
0.250
Why?
Carboplatin
6
1989
29
0.230
Why?
Pancreatic Neoplasms
1
1994
84
0.230
Why?
Cisplatin
4
1986
93
0.200
Why?
Survival Analysis
5
1994
589
0.200
Why?
Spiro Compounds
3
1988
5
0.200
Why?
Ifosfamide
5
1994
8
0.190
Why?
Fluorouracil
3
1986
78
0.190
Why?
Organometallic Compounds
3
1988
70
0.190
Why?
Organoplatinum Compounds
1
1989
5
0.180
Why?
Infusions, Intravenous
4
1987
143
0.180
Why?
Aged, 80 and over
5
1996
2588
0.180
Why?
Mitoxantrone
4
1984
20
0.170
Why?
Stomach Neoplasms
2
1999
40
0.170
Why?
Male
22
1980
20139
0.170
Why?
Mitomycins
2
1985
17
0.170
Why?
Carcinoma, Small Cell
2
1983
33
0.150
Why?
Neoplasm Staging
4
1996
354
0.150
Why?
Aclarubicin
2
1994
5
0.150
Why?
Folic Acid
1
1987
23
0.150
Why?
Aminoglutethimide
2
1981
6
0.150
Why?
Methotrexate
1
1985
73
0.130
Why?
Neoplasms
3
1992
743
0.120
Why?
Leukopenia
4
1984
26
0.120
Why?
Podophyllotoxin
1
1983
10
0.120
Why?
Allopurinol
2
1987
10
0.110
Why?
Hematologic Diseases
3
1985
40
0.100
Why?
Thrombocytopenia
3
1989
77
0.100
Why?
Budd-Chiari Syndrome
1
1980
9
0.090
Why?
Dacarbazine
1
1980
21
0.090
Why?
Drug-Induced Liver Injury
1
1980
36
0.090
Why?
Nausea
3
1981
155
0.090
Why?
Trimetrexate
1
1999
1
0.090
Why?
Antimetabolites, Antineoplastic
1
1999
40
0.090
Why?
Harringtonines
1
1999
2
0.090
Why?
Hydroxyurea
1
1999
14
0.090
Why?
Interferon-beta
1
1999
63
0.080
Why?
Vomiting
3
1982
116
0.080
Why?
Interleukin-2
1
1999
203
0.080
Why?
Survival Rate
3
1991
619
0.080
Why?
Sarcoma
2
1995
64
0.080
Why?
Colorectal Neoplasms
1
1999
143
0.070
Why?
Pilot Projects
4
1986
446
0.070
Why?
Gout Suppressants
1
1996
7
0.070
Why?
Radiation-Sensitizing Agents
1
1996
74
0.070
Why?
Lymphoma
2
1990
163
0.070
Why?
Uric Acid
1
1996
49
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
44
0.070
Why?
Mitomycin
2
1985
18
0.070
Why?
Carcinoma, Adenoid Cystic
1
1995
10
0.070
Why?
Mesna
1
1994
2
0.070
Why?
Pelvic Neoplasms
1
1994
15
0.060
Why?
Head and Neck Neoplasms
1
1995
84
0.060
Why?
Chemotherapy, Adjuvant
1
1994
88
0.060
Why?
Treatment Outcome
3
1994
2671
0.060
Why?
Vincristine
3
1986
61
0.060
Why?
Adjuvants, Immunologic
1
1994
118
0.060
Why?
Diarrhea
2
1987
65
0.060
Why?
Oncologic Nursing
1
1992
9
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Drug Therapy
1
1992
48
0.050
Why?
Medical Oncology
1
1992
49
0.050
Why?
Behavior Therapy
1
1992
110
0.050
Why?
Melphalan
1
1990
28
0.050
Why?
Multicenter Studies as Topic
1
1990
127
0.040
Why?
Anemia
1
1990
78
0.040
Why?
Random Allocation
1
1989
253
0.040
Why?
Leukemia, Myelomonocytic, Acute
1
1988
10
0.040
Why?
Hydrocortisone
1
1989
133
0.040
Why?
Bone Marrow Transplantation
1
1990
201
0.040
Why?
Catheterization, Central Venous
1
1988
56
0.040
Why?
Stomach
1
1988
80
0.040
Why?
Intestine, Small
1
1988
111
0.040
Why?
Prognosis
1
1989
1078
0.030
Why?
Skin Neoplasms
1
1988
230
0.030
Why?
Injections, Intravenous
2
1990
133
0.030
Why?
Anthraquinones
1
1984
6
0.030
Why?
Liver Neoplasms
1
1986
155
0.030
Why?
Melanoma
2
1980
132
0.030
Why?
Drug Therapy, Combination
2
1989
397
0.030
Why?
Prostatic Neoplasms
1
1989
540
0.030
Why?
Drug Resistance
1
1983
100
0.030
Why?
Sleep Stages
1
1981
21
0.030
Why?
Hormones
1
1981
64
0.020
Why?
Combined Modality Therapy
2
1986
491
0.020
Why?
Mitolactol
2
1989
6
0.020
Why?
Thiotepa
2
1989
8
0.020
Why?
Vinblastine
2
1989
27
0.020
Why?
Necrosis
1
1980
103
0.020
Why?
Dexamethasone
1
1981
188
0.020
Why?
Doxorubicin
2
1989
105
0.020
Why?
Antibiotics, Antineoplastic
1
1999
49
0.020
Why?
Drug Resistance, Neoplasm
1
1999
56
0.020
Why?
Safety
1
1999
106
0.020
Why?
Salvage Therapy
1
1999
62
0.020
Why?
Pain
1
1981
392
0.020
Why?
Ascitic Fluid
1
1996
22
0.020
Why?
Disease Progression
1
1999
533
0.020
Why?
Alopecia
1
1996
22
0.020
Why?
Treatment Failure
1
1996
131
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
1996
45
0.020
Why?
Fever
1
1996
109
0.020
Why?
Neutropenia
1
1996
70
0.020
Why?
Liver
1
1980
884
0.020
Why?
Cohort Studies
1
1999
984
0.020
Why?
Follow-Up Studies
2
1986
1889
0.020
Why?
Kidney
1
1996
589
0.010
Why?
Retrospective Studies
1
1999
2302
0.010
Why?
Time Factors
2
1989
3234
0.010
Why?
Cyclophosphamide
1
1991
177
0.010
Why?
Biological Availability
1
1990
38
0.010
Why?
Carmustine
1
1990
37
0.010
Why?
Fluoxymesterone
1
1989
4
0.010
Why?
Administration, Oral
1
1990
314
0.010
Why?
Randomized Controlled Trials as Topic
1
1992
415
0.010
Why?
Hematoma
1
1988
39
0.010
Why?
Motilin
1
1988
3
0.010
Why?
Periodicity
1
1988
41
0.010
Why?
Nervous System Diseases
1
1989
148
0.010
Why?
Dogs
1
1988
492
0.010
Why?
Palliative Care
1
1989
161
0.010
Why?
Electrophysiology
1
1988
249
0.010
Why?
Behavior, Animal
1
1988
239
0.010
Why?
Animals
1
1988
16416
0.000
Why?

Visualizations


Asbury's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department